James N Topper is Director of ANAPTYSBIO, INC. Currently has a direct ownership of 80,812 shares of ANAB, which is worth approximately $1.71 Million. The most recent transaction as insider was on Nov 16, 2020, when has been sold 48,958 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80.8K
0% 3M change
0% 12M change
Total Value Held $1.71 Million

James N Topper Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2020
BUY
Other acquisition or disposition
-
48,958 Added 37.73%
80,812 Common Stock

Also insider at

ALNA
Allena Pharmaceuticals, Inc. Healthcare
FLAC
Frazier Lifesciences Acquisition Corp Financial Services
ALPN
ALPINE IMMUNE SCIENCES, INC. Healthcare
PHAT
Phathom Pharmaceuticals, Inc. Healthcare
NAMS
NewAmsterdam Pharma Co N.V.
JNT

James N Topper

Director
Florham Park,, NJ

Track Institutional and Insider Activities on ANAB

Follow ANAPTYSBIO, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANAB shares.

Notify only if

Insider Trading

Get notified when an Anaptysbio, Inc insider buys or sells ANAB shares.

Notify only if

News

Receive news related to ANAPTYSBIO, INC

Track Activities on ANAB